MSB 3.21% $1.13 mesoblast limited

Ann: FDA Clears IND for Remestemcel Use in COVID-19 ARDS Patients, page-90

  1. 332 Posts.
    lightbulb Created with Sketch. 17
    "Ryoncil has shown results in 3 to 4 days"

    That's not true. As far as we know, Ryoncil (or Remestemcel-L) hasn't been administered to a single COVID-19 patient. Let's keep it factual (or at least somewhere near!!!)
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.